Journal
INVESTIGATIONAL NEW DRUGS
Volume 33, Issue 4, Pages 861-869Publisher
SPRINGER
DOI: 10.1007/s10637-015-0268-9
Keywords
Anthraquinones; Apoptosis; Damnacanthal; Cytotoxicity; Pentas schimperi; Rubiaceae
Categories
Funding
- Alexander von Humboldt Foundation
- DAAD
Ask authors/readers for more resources
Introduction Multidrug resistance in cancer represents a major problem in chemotherapy. The present study was designed to assess the cytotoxicity of anthraquinones from Pentas schimperi, namely damnacanthal (1), damnacanthol (2), 3-hydroxy-2-hydroxymethyl anthraquinone (3) and schimperiquinone B (4) against nine drug-sensitive and multidrug resistant (MDR) cancer cell lines. Methods The resazurin reduction assay was used to evaluate the cytotoxicity of the above compounds, whilst caspase-Glo assay was used to detect the activation of caspases enzymes by compounds 1 and 2. Cell cycle, mitochondrial membrane potential (MMP) and levels of reactive oxygen species were all analyzed via flow cytometry. Results Anthraquinones 1 and 2 displayed cytotoxic effects with IC50 values below 81 mu M on all the nine tested cancer cell lines whilst 3 and 4 displayed selective activities. The recorded IC50 values for compounds 1 and 2 ranged from 3.12 mu M and 12.18 mu M (towards leukemia CCRF-CEM cells) and from 30.32 mu M and 80.11 mu M (towards gliobastoma U87MG.Delta EGFR cells) respectively, and from 0.20 mu M (against CCRF-CEM cells) to 195.12 mu M (against CEM/ADR5000 cells) for doxorubicin. Compounds 1 and 2 induced apoptosis in CCRF-CEM leukemia cells, mediated by the disruption of the MMP and increase in ROS production. Conclusions Anthraquinones from Pentas schimperi and mostly 1 and 2 are potential cytotoxic natural products that deserve more investigations to develop novel antineoplastic drugs against multifactorial drug resistant cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available